In a recent article, BioInformant compared the top three largest cord blood banks within the United States. The purpose of the analysis was to consider comparative metrics between the largest market leaders in the cord blood industry within the United States, the most mature cord blood market worldwide. [Read more…]
Top Innovators in MSC Research Products: Who’s Leading in 2026?
The field of mesenchymal stem cell (MSC) research continues to gain momentum as scientists and innovators push the boundaries of regenerative medicine, tissue engineering, and biotechnology. From developing engineered tissues to advancing cell-based therapies, MSCs are at the heart of these groundbreaking efforts. As a result, the demand for high-quality MSC research products has grown rapidly. Whether you’re involved with research, clinical applications, or biomanufacturing, knowing where to find reliable MSC tools is essential for success. [Read more…]
What is Cell Reprogramming and What Does It Mean?
Can you imagine a world where doctors have the power to replace dead, disease-causing cells with healthy ones produced in a laboratory? With continued research into cell reprogramming that future isn’t far off. There have already been several successful trials with this technology. Despite its immense potential and expanding use, many individuals still remain unfamiliar with the concept of cell reprogramming.
So, what is cell reprogramming? And what are some of the obstacles that the field faces today? In this quick summary of cell reprogramming, we’ll answer these questions and more. [Read more…]
SB431542 Unlocking the Potential of Mouse Embryonic Stem Cells
Mouse embryonic stem cells (mESCs) have long stood as a cornerstone of regenerative medicine and developmental biology research. Derived from the inner cell mass of blastocyst-stage mouse embryos, these cells possess two defining characteristics: pluripotency, the ability to differentiate into any cell type in the adult body, and self-renewal, the capacity to divide indefinitely while maintaining that pluripotent state. Harnessing these properties, however, requires precise control over the cellular signaling pathways that govern mESC fate. This is where SB431542, a small molecule inhibitor, emerges as a powerful tool—one that has revolutionized how researchers manipulate mESCs in the lab. [Read more…]
Cord Blood Industry Trends – Clinical Trials, Publications, Patents, Grants, & More
With the global cord blood banking industry maturing and consolidating over the past five years, it is more important than ever to be well-educated about cord blood industry trends. There are now fewer market players, because numerous small cord blood banks have either been acquired or gone out of business.
However, this era of maturation and consolidation has had as many benefits to surviving cord blood banks as drawbacks. On average, the remaining market participants are now larger, stronger, better capitalized, and storing larger quantities of cord blood and tissue units than when the market was more fragmented.
- « Previous Page
- 1
- …
- 28
- 29
- 30
- 31
- 32
- …
- 336
- Next Page »